Lista de obras - Carlo Genova - Dominio Público Uruguay

ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium

artículo científico publicado en 2020

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

artículo científico publicado en 2018

Afatinib for the treatment of advanced non-small-cell lung cancer.

artículo científico publicado en 2014

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

artículo científico publicado en 2014

Antitumor activity of larotrectinib in tumors harboring gene fusions: a short review on the current evidence

article

Belagenpumatucel-L for the treatment of non-small cell lung cancer

artículo científico

CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine

artículo científico publicado en 2018

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

artículo científico publicado en 2017

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

artículo científico publicado en 2014

Clinical potential of necitumumab in non-small cell lung carcinoma

artículo científico publicado en 2016

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 01 October 2019

Efficacy of motesanib diphosphate in non-small-cell lung cancer

artículo científico publicado en 2014

Erratum: Antitumor Activity of Larotrectinib in Tumors Harboring NTRK Gene Fusions: A Short Review on the Current Evidence [Corrigendum]

scientific article published on 11 May 2020

Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer

artículo científico publicado en 2015

Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy ⬇️

artículo científico publicado el 4 de mayo de 2013

Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients

artículo científico publicado en 2013

Hematopoietic growth factors in lung cancer.

artículo científico publicado en 2016

Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation

scientific article published on 30 May 2016

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

scientific article published on 21 January 2019

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.

artículo científico publicado en 2019

Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer

artículo científico publicado en 2017

Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

artículo científico publicado en 2012

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

artículo científico

Looking for results in non-small-cell lung cancer: is bio-chemotherapy the right answer?

artículo científico publicado en 2014

New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer.

artículo científico publicado en 2016

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

artículo científico publicado en 2015

Oral vinorelbine in the treatment of non-small-cell lung cancer.

artículo científico

Pemetrexed for the treatment of non-small cell lung cancer.

artículo científico publicado en 2013

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

artículo científico publicado en 2016

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

scientific article published on 30 April 2020

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

artículo científico publicado en 2014

Radiomic detection of EGFR mutations in NSCLC

scientific article published on 04 November 2020

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer

scientific article published on 28 October 2019

Recent advances in squamous non-small cell lung cancer: evidence beyond predictive biomarkers.

artículo científico publicado en 2015

Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer.

artículo científico publicado en 2017

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

scientific article published on 11 February 2020

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

artículo científico

Role of microRNAs in malignant mesothelioma.

artículo científico

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

artículo científico publicado en 2015

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

scientific article published on 20 July 2019

Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.

artículo científico publicado en 2016

Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives

artículo científico publicado en 2020

The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib.

artículo científico publicado en 2012

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

article

Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview

artículo científico publicado en 2014

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

artículo científico publicado en 2015

Vinflunine for the treatment of non-small cell lung cancer.

artículo científico publicado en 2016

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report

artículo científico publicado en 2016

Lista de obras de Carlo Genova

ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Afatinib for the treatment of advanced non-small-cell lung cancer.

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

Antitumor activity of larotrectinib in tumors harboring gene fusions: a short review on the current evidence

Belagenpumatucel-L for the treatment of non-small cell lung cancer

CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

Clinical potential of necitumumab in non-small cell lung carcinoma

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

Efficacy of motesanib diphosphate in non-small-cell lung cancer

Erratum: Antitumor Activity of Larotrectinib in Tumors Harboring NTRK Gene Fusions: A Short Review on the Current Evidence [Corrigendum]

Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer

Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy ⬇️

Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients

Hematopoietic growth factors in lung cancer.

Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.

Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer

Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy.

Looking for results in non-small-cell lung cancer: is bio-chemotherapy the right answer?

New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer.

Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform

Oral vinorelbine in the treatment of non-small-cell lung cancer.

Pemetrexed for the treatment of non-small cell lung cancer.

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer.

Radiomic detection of EGFR mutations in NSCLC

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer

Recent advances in squamous non-small cell lung cancer: evidence beyond predictive biomarkers.

Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer.

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.

Role of microRNAs in malignant mesothelioma.

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.

Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives

The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib.

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview

Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

Vinflunine for the treatment of non-small cell lung cancer.

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report